Three-year multinational clinical study on an aspheric hydrophobic acrylic intraocular lens.

ABSTRACT:

Purpose

To present the results of a study investigating the 3-year effectiveness and safety of the Clareon single-piece intraocular lens (IOL).

Setting

19 multinational sites.

Design

Prospective multicenter single-arm study.

Methods

Patients were bilaterally implanted with Clareon IOLs. Assessments included uncorrected distance visual acuity, corrected distance visual acuity (CDVA), manifest refraction, tilt, decentration, applanation tonometry, and fundus examination, including glistenings and posterior capsule opacification (PCO) evaluation. The primary outcomes for effectiveness and safety were evaluated at 1 year and compared with ISO historical safety and performance endpoint (SPE) rates. Patients were followed for up to 3 years after implantation.

Resu

SUBMITTER: Nuijts RMMA 

PROVIDER: S-EPMC10284131 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature